The journal Breast Cancer: Targets and Therapy, a Dove Medical Press title, has retracted four articles from a group of Indian researchers over what it said were ?unacceptable levels? of duplication with other published work. (Such a construction leaves us wondering what might constitute ?acceptable levels? of duplication, but that?s for a different post.)
The articles were submitted by Rajeev Singhai, who is listed as being with Grant Medical College and the Sir J J Group of Hospitals, in Mumbai. According to his After College page, Singhai received his PhD in 2011 and is now a research fellow.
As the notice states:
The Editor-in-Chief and Publisher of Breast Cancer: Targets and Therapy have been alerted to unacceptable levels of duplication with previously published papers. All four papers were submitted by Dr Rajeev Singhai.
It is worth noting that all papers were peer-reviewed by a minimum of two peer-reviewers and the Editor-in-Chief of Breast Cancer: Targets and Therapy before publication. The papers concerned are:
Patil VW, Tayade MB, Pingale SA, et al. The p53 breast cancer tissue biomarker in Indian women. Breast Cancer: Targets and Therapy. 2011;3:71?78.
Singhai R, Patil AV, Patil VW. Cancer biomarker HER-2/neu in breast cancer in Indian women. Breast Cancer: Targets and Therapy. 2011;3:21?26.
Patil AV, Bhamre RS, Singhai R, Tayade MB, Patil VW. Estrogen receptor (ER) and progesterone receptor (PgR) in breast cancer of Indian women. Breast Cancer: Targets and Therapy. 2011;3:27?33.
Patil VW, Singhai R, Patil AV, Gurav PD. Triple-negative (ER, PgR, HER-2/neu) breast cancer in Indian women. Breast Cancer: Targets and Therapy. 2011;3:9?19.
Hat tip: Clare Francis
Like this:
Be the first to like this post.
andy dalton corporal kelsey de santis corporal kelsey de santis juan manuel marquez juan manuel marquez stanford oregon velasquez vs dos santos
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.